Teachers Retirement System of The State of Kentucky Has $3.94 Million Holdings in Humana Inc. (NYSE:HUM)

Teachers Retirement System of The State of Kentucky lessened its stake in Humana Inc. (NYSE:HUMGet Rating) by 4.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,054 shares of the insurance provider’s stock after selling 394 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in Humana were worth $3,940,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HUM. Wellington Management Group LLP increased its position in Humana by 38.8% in the 1st quarter. Wellington Management Group LLP now owns 8,775,376 shares of the insurance provider’s stock valued at $3,818,781,000 after acquiring an additional 2,453,565 shares in the last quarter. Capital Research Global Investors increased its position in Humana by 49.5% in the 4th quarter. Capital Research Global Investors now owns 3,872,000 shares of the insurance provider’s stock valued at $1,796,075,000 after acquiring an additional 1,281,466 shares in the last quarter. Norges Bank acquired a new stake in Humana in the 4th quarter valued at about $563,554,000. GQG Partners LLC increased its position in Humana by 86,541.6% in the 4th quarter. GQG Partners LLC now owns 1,139,337 shares of the insurance provider’s stock valued at $528,420,000 after acquiring an additional 1,138,022 shares in the last quarter. Finally, Starboard Value LP acquired a new stake in shares of Humana during the 1st quarter worth approximately $421,332,000. Institutional investors and hedge funds own 93.50% of the company’s stock.

Humana Stock Performance

Shares of HUM opened at $499.79 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.53 and a current ratio of 1.53. Humana Inc. has a twelve month low of $351.20 and a twelve month high of $504.99. The firm’s 50 day moving average price is $486.23 and its two-hundred day moving average price is $459.41. The firm has a market cap of $63.25 billion, a P/E ratio of 20.40, a PEG ratio of 1.49 and a beta of 0.77.

Humana (NYSE:HUMGet Rating) last announced its quarterly earnings data on Wednesday, July 27th. The insurance provider reported $8.67 EPS for the quarter, topping analysts’ consensus estimates of $7.67 by $1.00. The business had revenue of $23.66 billion for the quarter, compared to analyst estimates of $23.44 billion. Humana had a net margin of 3.52% and a return on equity of 18.42%. The firm’s revenue for the quarter was up 14.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.89 earnings per share. On average, analysts forecast that Humana Inc. will post 25.04 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be given a $0.7875 dividend. This represents a $3.15 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, September 29th. Humana’s dividend payout ratio is presently 12.86%.

Analysts Set New Price Targets

HUM has been the subject of several analyst reports. Credit Suisse Group set a $548.00 price target on shares of Humana in a research report on Tuesday, July 19th. Sanford C. Bernstein initiated coverage on shares of Humana in a research report on Thursday, May 26th. They set a “market perform” rating and a $506.00 price target for the company. Morgan Stanley lifted their price target on shares of Humana from $453.00 to $494.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 2nd. Cowen lifted their price target on shares of Humana to $547.00 in a research report on Tuesday, August 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Humana from $450.00 to $514.00 in a research report on Thursday, July 28th. Five investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $515.17.

Humana Company Profile

(Get Rating)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMGet Rating).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.